4dmedical Ltd has released a press release.
GSK contract, UK clearance for CTVQ, and ASX 200 inclusion
Earlier from 4dmedical
- Insignia Financial to be removed from the S&P/ASX 200 Index
- 4DMedical receives CE Mark for CT: VQ™, enabling commercial launch across the European Union